DGMed ECT Portal
TR EN

Group: Musculoskeletal & CNS

ECT: Early clinical literature39 publications

Bone & Soft Tissue Sarcomas

In bone metastases and soft tissue sarcomas, electrochemotherapy has been studied for pain palliation, local control and preoperative volume reduction. The high impedance of bone and the need for imaging guidance in electrode placement are technical themes specific to this area.

64total publications
25clinical publications
27preclinical publications
11reviews
1997–2026publication span

Clinical publications: randomized, prospective and retrospective studies, case series and case reports. Preclinical publications: animal, in vitro, modelling and experimental biophysics studies.

Literature Status by Method

Publication count, clinical and preclinical split, literature maturity and publication span for each clinical method. The badge at the top of the page summarises the ECT record only; the full split by method is here.

Electrochemotherapy (ECT)

39publications
18clinical publications
17preclinical publications

Early clinical literaturethreshold 8/39

Validated records entering the maturity calculation: 8 (clinical 5, preclinical 2), 21% of the records for this method.

1997–2026

Irreversible electroporation (IRE)

13publications
6clinical publications
4preclinical publications

Exploratory literaturethreshold 3/13

Validated records entering the maturity calculation: 3 (clinical 1, preclinical 0), 23% of the records for this method.

2011–2026

Calcium electroporation

1publication
0clinical publications
0preclinical publications

Exploratory literaturethreshold 0/1

No record for this method entered the maturity calculation; the records are marked in the validation ledger as conflicting, insufficient or out of scope.

2019–2019

Gene electrotransfer

3publications
0clinical publications
3preclinical publications

Exploratory literaturethreshold 0/3

No record for this method entered the maturity calculation; the records are marked in the validation ledger as conflicting, insufficient or out of scope.

2006–2013

Other electroporation applications

8publications
1clinical publication
3preclinical publications

This set does not name a single clinical method; no literature maturity is assigned.

2000–2024

Mechanisms Mentioned in Abstracts

Mechanism names are detected by automatic matching over publication abstracts; the figure is the number of publications containing the name. A mention does not mean the mechanism was demonstrated in that study.

Reversible Membrane Permeabilisation 19 Increased Intracellular Bleomycin Accumulation 18 Irreversible Pore Formation and Cell Death 15 Increased Intracellular Cisplatin Accumulation 9 Electric Field Distribution and Modelling 9 Potentiation of Cytotoxic Drug Permeability 7 Electrode Geometry and Placement 7 Necrosis and Necroptosis 5 Haemostasis and Bleeding Control 4 Gene Electrotransfer (Plasmid DNA) 3 Apoptosis Induction 3 Systemic / Abscopal Immune Response 2

Study Type Distribution

Bar length is scaled to the most common study type; the percentage gives the share of the whole area. Colour marks the study-type band, on the same scale as the literature map.

Study typePublicationsShare within this area
Prospective Clinical Study2
3%
Clinical Study8
12%
Retrospective Clinical Study1
2%
Case Series1
2%
Case Report13
20%
Review11
17%
Animal Study20
31%
In Vitro Study2
3%
In Silico / Modelling4
6%
Experimental Biophysics Study1
2%
Correction / Erratum1
2%

Literature Evidence Table

64 publications listed in order of evidence strength. Click a title to open the citation, mechanism and full abstract drawer.

The study type, model and mechanism columns are assigned automatically and can be wrong for individual records; the abstract column is taken either from the publication's own abstract or from the opening text of the source PDF. The labels are there for scanning and filtering, not as record-level verified data; consult the full text before acting on any single publication. The classification rules and known errors are on the Literature Map.

64 publications shown

RegimePublicationYearStudy typeModelMechanismAbstract
ECT
Ottlakan et al · Bioelectrochemistry
2022Prospective Clinical StudyHumanIncreased Intracellular Bleomycin Accumulation, Electrode Geometry and PlacementThe aim of the current prospective pilot study exclusively for deep-seated soft tissue sarcomas (STS) was to evaluate efficacy and safety of bleomycin-based ECT using VEG (variable electrode…
IRE
Martin et al · BMC Cancer
2014Prospective Clinical StudyHumanIrreversible Pore Formation and Cell Death, Reversible Membrane PermeabilisationBackground: Irreversible electroporation (IRE) has recently been added as an additional therapeutic ablative option in patients with locally advanced cancers (LAC) involving vital structures…
ECT
Cevolani et al · J Surg Oncol
2023Clinical StudyHumanNecrosis and NecroptosisBackground: Bone metastases are frequent in patients with cancer. Electrochemotherapy (ECT) is a minimally invasive treatment based on a high-voltage electric pulse combined with an anticanc…
ECT
Campanacci et al · Curr Oncol
2022Clinical StudyHumanBone metastases induce pain, risk of fracture, and neural compression, and reduced mobility and quality of life. Electrochemotherapy (ECT) is a minimally invasive local treatment based on a …
ECT
Campanacci et al · Eur J Surg Oncol
2021Clinical StudyHumanIntroduction: Bone metastases are frequent in patients with cancer. Electrochemotherapy (ECT) is a minimally invasive treatment. Preclinical and clinical studies supported the use of ECT in …
ECT
Simioni et al · Sci Rep
2020Clinical StudyHumanIncreased Intracellular Bleomycin Accumulation, Electrode Geometry and PlacementStandard electrochemotherapy (ECT) is effective in many tumour types but is confined to the treatment of small superficial lesions. Variable electrode-geometry ECT (VEG-ECT) may overcome the…
ECT
Bianchi et al · World J Surg
2016Clinical StudyHumanIntroduction: Bone metastatic disease is a major cause of pain and decreased quality of life in patients with cancer. In addition to systemic therapy and pain control with narcotic analgesic…
ECT
Guida et al · Annals of Oncology
2016Clinical StudyHumanAngiosarcoma is an aggressive vascular neoplasm with a high propensity for local recurrence. Electrochemotherapy is an emerging skin-directed therapy, © The Author 2016. Published by Oxford …
ECT
Guida et al · European Journal of Surgical Oncology (EJSO)
2016Clinical StudyHumanIncreased Intracellular Bleomycin Accumulation, Antivascular Effect and Vessel DisruptionAngiosarcoma is an aggressive vascular neoplasm with a high propensity for local recurrence. Electrochemotherapy is an emerging skin-directed therapy, which exerts prominent anti-tumour acti…
ECT
Campana et al · World J Surg
2013Clinical StudyHumanElectrode Geometry and Placement, Increased Intracellular Bleomycin AccumulationAims: Our aim was to evaluate the activity, toxicity, and feasibility of electrochemotherapy (ECT) in patients with soft-tissue sarcomas (STS). Methods: A two-stage phase II trial was conduc…
ECT
Deschamps et al · Eur J Cancer
2023Retrospective Clinical StudyHumanIncreased Intracellular Bleomycin AccumulationObjective: To report efficacy and safety of percutaneous electrochemotherapy (ECT) in patients with radiotherapy-resistant metastatic epidural spinal cord compression (MESCC). Material/ meth…
ECT
Tedesco et al · J Clin Med
2024Case SeriesHumanIncreased Intracellular Bleomycin Accumulation(1) Background: this case series and literature review aims to evaluate the efficacy and safety of electrochemotherapy in the management of aggressive spinal hemangiomas, presenting two dist…
ECT
Siew et al · Cardiovasc Intervent Radiol
2026Case ReportHumanReversible Membrane Permeabilisation, Electrode Geometry and PlacementVertebral haemangiomas are benign lesions that developed from vascular proliferation within bone marrow spaces [1]. As these malformations do not grow by mitotic activity and lack any malign…
IRE
Pusceddu · Diagn Interv Radiol
2026Case ReportHumanReversible Membrane Permeabilisation, Irreversible Pore Formation and Cell DeathBone metastases are common in advanced solid tumors and often require local control strategies in addition to systemic therapy. Although thermal ablation is an established method for selecte…
ECT
Angelini et al · Diagnostics (Basel)
2024Case ReportHumanNecrosis and NecroptosisMetastases are complications of primary tumors due to prolonged cancer survival and have become an important issue for oncological patients and the most frequent cause of death and disabilit…
ECT
Parisi et al · –
2023Case ReportHaemostasis and Bleeding ControlBreast Angiosarcoma is a rare malignancy, accounting less than 1% of all soft tissue. It comprises primitive and secondary subtypes, such as radiogenic breast angiosarcoma (RAS). Despite the…
ECT
Albertini et al · Case Rep Med
2020Case ReportHumanIntroduction Metastatic bone disease represents a systemic pathology that heavily affects the quality of life of oncologic patients causing pain and functional disability. Methodology . We p…
ECT
Cornelis et al · Cardiovasc Intervent Radiol
2019Case ReportHumanTwo patients underwent percutaneous image-guided electrochemotherapy on blastic spine metastases involving posterior walls of the lumbar vertebral bodies with epidural extension. These treat…
IRE
Qin et al · Technol Cancer Res Treat
2017Case ReportHumanReversible Membrane Permeabilisation, Irreversible Pore Formation and Cell DeathPurpose: To explore the safety and efficacy of irreversible electroporation ablation in unresectable fibrous sarcoma with 2 electrodes. Methods: A 74-year-old woman with unresectable retrope…
Other EP
Mocerino et al · Int J Immunopathol Pharmacol
2016Case ReportHumanIncreased Intracellular Bleomycin AccumulationAngiosarcomas are malignant tumors of endovascular origin, which may be divided into primary and secondary forms. Secondary breast angiosarcomas are an increasing problem, especially in pati…
IRE
Harris et al · J Pediatr Hematol Oncol
2016Case ReportHumanIrreversible Pore Formation and Cell Death, Reversible Membrane PermeabilisationIrreversible electroporation (IRE) induces apoptosis in tumor cells with electric energy, allowing treatment of unresectable tumors. One potential application is metastatic osteosarcoma (OS)…
IRE
Steinbrecher et al · BMJ Case Rep
2016Case ReportHumanIrreversible Pore Formation and Cell Death, Reversible Membrane PermeabilisationEwing's sarcoma (ES) is the second most common paediatric cancer of the bone. Standard therapy includes surgery or radiation for local control of primary and relapsed lesions and chemotherap…
ECT
Bonadies et al · Anticancer Res
2015Case ReportHumanDermatofibrosarcoma protuberans (DFSP) is an uncommon cutaneous sarcoma with high recurrence rate. Radical surgery is the treatment of choice, although in cosmetically-sensitive areas such a…
IRE
Neal et al · J Clin Oncol
2011Case ReportHumanIrreversible Pore Formation and Cell Death, Reversible Membrane PermeabilisationIrreversible electroporation (IRE) is a promising technique for the focal treatment of pathologic tissues that involves placing minimally invasive electrodes within the targeted region. A se…
ECT
Shimizu et al · J Orthop Sci
2003Case ReportHumanIncreased Intracellular Bleomycin Accumulation, Necrosis and NecroptosisElectrochemotherapy (ECT) delivers nonpermeable anticancer drugs to cell interiors by temporally increasing the permeability of the cytoplasmic membrane under locally applied pulsating elect…
ECT
Deschamps et al · Br J Radiol
2025ReviewHumanElectric Field Distribution and ModellingThis review aims to analyse the safety and clinical efficacy in terms of pain relief and local tumour control, in patients with metastatic epidural spinal cord compression undergoing electro…
Other EP
Berry-Kilgour · Front Bioeng Biotechnol
2024ReviewLiterature AnalysisPreservation of Extracellular Matrix and Tissue Scaffold, Electric Field Distribution and ModellingTissue engineering encompasses a range of techniques that direct the growth of cells into a living tissue construct for regenerative medicine applications, disease models, drug discovery, an…
ECT
Parisi et al · J Clin Med
2024ReviewLiterature AnalysisHaemostasis and Bleeding ControlBreast angiosarcoma is a rare malignancy, accounting for less than 1% of all soft tissue cancers. It comprises primitive and secondary subtypes, such as radiogenic breast angiosarcoma (RAS).…
ECT
Martin et al · Bioengineering (Basel)
2023ReviewLiterature AnalysisIncreased Intracellular Bleomycin AccumulationThe primary aim of this study was to analyze studies that use electrochemotherapy (ECT) in "deep-seated" tumors in solid organs (liver, kidney, bone metastasis, pancreas, and abdomen) and un…
Other EP
Shu · Life (Basel)
2023ReviewLiterature AnalysisReversible Membrane Permeabilisation, Irreversible Pore Formation and Cell DeathSoft tissue tumors (STTs) include a range of benign and malignant tumors originating from soft tissues. Transarterial and percutaneous therapies are image-guided and minimally invasive appro…
IRE
Sun et al · Anticancer Res
2023ReviewHumanIrreversible Pore Formation and Cell Death, Reversible Membrane PermeabilisationOsteosarcoma is the most common primary bone malignancy, and surgical resection combined with neoadjuvant chemotherapy is the gold-standard treatment for affected patients. Although the over…
Other EP
Tsukamoto et al · Curr Oncol
2021ReviewHumanThe number of patients with bone metastasis increases as medical management and surgery improve the overall survival of patients with cancer. Bone metastasis can cause skeletal complications…
IRE
Sundararajan et al · JCPCR
2019ReviewLiterature AnalysisIrreversible Pore Formation and Cell Death, Reversible Membrane PermeabilisationVolume 10 Issue 5 - 2019 Sarcomas are cancers that occur in soft tissues and bones that mostly affect teenagers and young adults. Although its occurrence is rare, the affect is huge-metastat…
IRE
Vailas et al · J BUON
2019ReviewHumanIrreversible Pore Formation and Cell Death, Reversible Membrane PermeabilisationSarcomas arise from uncontrolled cell growth in tissues of mesodermal origins, such as connective tissue, bone, cartilage, fat or muscle. Surgical resection is still considered the cornersto…
Other EP
Mavrogenis et al · Clin J Pain
2016ReviewHumanBackground: Metastatic disease is the most common malignancy of the bone. Prostate, breast, lung, kidney, and thyroid cancer account for 80% of skeletal metastases. Bone metastases are assoc…
ECT
Spugnini et al · Int J Biochem Cell Biol
2008ReviewAnimal (In Vivo)Local management of soft tissue sarcoma in humans generally involves multi-modality approaches whose cornerstones are surgery combined with radiation therapy. The usual radiation protocols a…
ECT
Deschamps et al · Eur Radiol Exp
2025Animal StudyAnimal (In Vivo)Haemostasis and Bleeding Control, Apoptosis InductionBackground: Electrochemotherapy (ECT) of vertebral metastasis is a new treatment option for metastasis that is not accessible to thermal ablation or radiotherapy. A numerical feasibility stu…
ECT
Kranjc et al · Radiol Oncol
2017Animal StudyAnimal (In Vivo)Increased Intracellular Cisplatin Accumulation, Reversible Membrane PermeabilisationBackground: Cisplatin is used in cancer therapy, but its side effects and acquired resistance to cisplatin have led to the synthesis and evaluation of new platinum compounds. Recently, the s…
IRE
Tschon et al · Technol Cancer Res Treat
2016Animal StudyAnimal (In Vivo)Reversible Membrane Permeabilisation, Irreversible Pore Formation and Cell DeathSkeletal metastases are a common cause of severe morbidity, reduction in quality of life and often early mortality. Consequently, improvements in therapies are necessary. Electroporation use…
IRE
Tam et al · Radiology
2016Animal StudyAnimal (In Vivo)Irreversible Pore Formation and Cell Death, Electric Field Distribution and ModellingPurpose To determine the effects of irreversible electroporation (IRE) on the neural tissues after ablation in the epidural space of the porcine spine. Materials and Methods The institutiona…
ECT
Cemazar et al · Radiol Oncol
2015Animal StudyAnimal (In Vivo)Increased Intracellular Cisplatin Accumulation, Potentiation of Cytotoxic Drug PermeabilityBackground: Electrochemotherapy is a tumour ablation modality, based on electroporation of the cell membrane, allowing non-permeant anticancer drugs to enter the cell, thus augmenting their …
IRE
Song et al · Sci Rep
2015Animal StudyAnimal (In Vivo)Irreversible Pore Formation and Cell Death, Reversible Membrane PermeabilisationIrreversible electroporation (IRE) is a novel ablation method that has been tested in humans with lung, prostate, kidney, liver, lymph node and presacral cancers. As a new non-thermal treatm…
ECT
Fini et al · Clin Exp Metastasis
2013Animal StudyAnimal (In Vivo)Increased Intracellular Bleomycin AccumulationBone metastases impair general health status, quality of life and survival of patients. Electrochemotherapy (ECT), which combines electroporation (EP) and the administration of anticancer dr…
Gene ET
Sedlar · BMC Cancer
2013Animal StudyAnimal (In Vivo)Gene Electrotransfer (Plasmid DNA), Interleukin-12 Mediated Immune StimulationBackground: Interleukin-12 (IL-12) based radiosensitization is an effective way of tumor treatment. Local cytokine production, without systemic shedding, might provide clinical benefit in ra…
Gene ET
Sedlar et al · Radiol Oncol
2012Animal StudyAnimal (In Vivo)Gene Electrotransfer (Plasmid DNA), Interleukin-12 Mediated Immune StimulationBACKGROUND.: Electrochemotherapy provides good local tumor control but requires adjuvant treatment for increased local response and action on distant metastasis. In relation to this, intramu…
IRE
Li et al · PLoS One
2012Animal StudyAnimal (In Vivo)Irreversible Pore Formation and Cell Death, Reversible Membrane PermeabilisationBackground: Irreversible electroporation (IRE) is a promising technique for the focal treatment of pathologic tissues, which involves placing minimally invasive electrodes within the targete…
ECT
Spugnini et al · J Transl Med
2011Animal StudyAnimal (In Vivo)Increased Intracellular Cisplatin AccumulationBackground: Cancer is one of the most difficult current health challenges, being responsible for millions of deaths yearly. Systemic chemotherapy is the most common therapeutic approach, and…
Other EP
Fini et al · J Bone Joint Surg Br
2010Animal StudyAnimal (In Vivo)Short intense electrical pulses transiently increase the permeability of the cell membrane, an effect known as electroporation. This can be combined with antiblastic drugs for ablation of tu…
Gene ET
Grosel et al · DNA Cell Biol
2006Animal StudyAnimal (In Vivo)Gene Electrotransfer (Plasmid DNA), Increased Intracellular Cisplatin AccumulationThe aim of our study was to evaluate feasibility and therapeutic potential of electrogene therapy with p53 alone or combined with electrochemotherapy using cisplatin on two murine sarcomas w…
ECT
Spugnini et al · Cancer Chemother Pharmacol
2006Animal StudyAnimal (In Vivo)Increased Intracellular Bleomycin AccumulationFeline soft tissue sarcomas are spontaneous, rapidly growing, and aggressive neoplasms that mimic their human counterpart. The purpose of this study was to evaluate the feasibility and effic…
ECT
Kranjc et al · BMC Cancer
2005Animal StudyAnimal (In Vivo)Increased Intracellular Bleomycin Accumulation, Potentiation of Cytotoxic Drug PermeabilityBackground: Bleomycin is poorly permeant but potent cytotoxic and radiosensitizing drug. The aim of the study was to evaluate whether a physical drug delivery system - electroporation can in…
ECT
Isobe et al · Clin Orthop Relat Res
2004Animal StudyAnimal (In Vivo)Potentiation of Cytotoxic Drug PermeabilityMethotrexate plays a key role in adjuvant chemotherapy for treatment of osteosarcoma, but is used at a high dose because it can pass through a cell membrane only with difficulty. Therefore, …
ECT
Jaroszeski et al · Technol Cancer Res Treat
2002Animal StudyAnimal (In Vivo)Increased Intracellular Bleomycin Accumulation, Reversible Membrane PermeabilisationElectrochemotherapy is the combined use of a chemotherapeutic agent and pulsed electric fields. Electrical treatment causes an increase in cell membrane permeability which allows the chemoth…
Other EP
A Horiuchi, T Nikaido, J Mitsushita, T Toki, I Konishi, S Fujii · International Journal of Cancer
2000Animal StudyAnimal (In Vivo)Increased Intracellular Bleomycin Accumulation, Systemic / Abscopal Immune ResponseInt. J. Cancer: 88, 640 – 644 (2000) © 2000 Wiley-Liss, Inc. Publication of the International Union Against Cancer ENHANCEMENT OF ANTITUMOR EFFECT OF BLEOMYCIN BY LOW-VOLTAGE IN VIVO ELECTRO…
ECT
M Hyacinthe, M Jaroszeski, V Dang, D Coppola, R Karl, R Gilbert · Cancer
1999Animal StudyAnimal (In Vivo)Potentiation of Cytotoxic Drug Permeability, Increased Intracellular Bleomycin AccumulationPulsed electric fields have been shown to increase the effectiveness of antineoplastic agents by temporarily increasing the permeability of cell membranes. This type of drug delivery is call…
ECT
Sersˇa et al · Bioelectrochemistry and Bioenergetics
1997Animal StudyAnimal (In Vivo)Increased Intracellular Bleomycin Accumulation, Potentiation of Cytotoxic Drug PermeabilityElectrochemotherapy combines chemotherapy with electric pulses in order to potentiate anti-tumor effectiveness of chemotherapeutic drugs. Electrochemotherapy with drugs that normally do not …
ECT
Michel et al · Biotechnol Appl Biochem
2019In Vitro StudyCell CultureReversible Membrane Permeabilisation, Increased Intracellular Cisplatin AccumulationPrimary cell cultures are challenging, but reliable model reflecting tumor response in vitro. The study was designed to examine if the increased electropermeabilization can overcame initial …
Other EP
Gill et al · Oncotarget
2018In Vitro StudyCell CultureIncreased Intracellular Cisplatin AccumulationBackground: Osteosarcoma accounts for roughly 60% of all malignant bone tumors in children and young adults. The five-year survival rate for localized tumors after surgery and chemotherapy i…
ECT
Cindrič et al · Cancers (Basel)
2022In Silico / ModellingComputational ModelElectric Field Distribution and Modelling, Reversible Membrane PermeabilisationElectroporation-based treatments such as electrochemotherapy and irreversible electroporation ablation have sparked interest with respect to their use in medicine. Treatment planning involve…
ECT
Cindrič et al · Technol Cancer Res Treat
2018In Silico / ModellingComputational ModelElectric Field Distribution and Modelling, Electrode Geometry and PlacementVertebral column is the most frequent site for bone metastases. It has been demonstrated in previous studies that bone metastases can be efficiently treated by electrochemotherapy. We develo…
ECT
Campana et al · Technol Cancer Res Treat
2018In Silico / ModellingHumanElectric Field Distribution and Modelling, Tissue Conductivity and Impedance ChangeElectrochemotherapy is an established treatment option for patients with superficially metastatic tumors, mainly malignant melanoma and breast cancer. Based on preliminary experiences, elect…
ECT
Ongaro et al · Technol Cancer Res Treat
2015In Silico / ModellingComputational ModelElectric Field Distribution and Modelling, Electrode Geometry and PlacementElectrochemotherapy (ECT) is a local anticancer treatment based on the combination of chemotherapy and short, tumor-permeabilizing, voltage pulses delivered using needle electrodes or plate …
ECT
Tosi et al · Med Biol Eng Comput
2016Experimental Biophysics StudyHumanTissue Conductivity and Impedance ChangeTissue electrical conductivity is correlated with tissue characteristics. In this work, some soft tissue sarcomas (STS) excised from patients have been evaluated in terms of histological cha…
Calcium EP
Szewczyk · Oncotarget
2019Correction / ErratumCalcium Electroporation and ATP Depletion[This corrects the article DOI: 10.18632/oncotarget.24352.].

Limitations

The counts on this page are bounded by the scope of the source PDF archive and are not a systematic review of the area's literature.

A literature maturity label reflects the number of publications, not their methodological quality: it describes how much literature exists in the area and of what kind, not how strongly the treatment is supported. It does not indicate clinical use, guideline endorsement, reimbursement coverage or regulatory status, and it is not a formal GRADE assessment. The definitions and thresholds of the four tiers are on the Literature Map.

The “clinical publications” figure on this page (25) uses the portal's single definition: primary clinical studies, case series and case reports. Systematic reviews and guidelines are not included. The count feeding the badge threshold is narrower and does not count case reports; in this area 6 publications enter that threshold count across every method together (ECT 5 · IRE 1 · Calcium EP 0 · Gene ET 0 · Other EP 0), whereas the badge at the top of the page rests on the ECT count alone. The two counts are not the same and cannot stand in for one another; the full threshold table is on the Literature Map.

11 of the 64 records in this area enter the threshold count. The remaining 53 are marked in the validation ledger as conflicting, insufficient or out of scoring; they appear in the table below but affect no threshold and no badge. That share (17%) is not equal across areas: it is 13% portal-wide and ranges from 0% to 42% by area. Two areas' badges therefore cannot be compared directly; a lower badge can reflect narrower verification coverage as much as a narrower literature.

Literature maturity on this page is given separately for each clinical method. The methods present in this area are: Electrochemotherapy (ECT), Irreversible electroporation (IRE), Calcium electroporation, Gene electrotransfer, Other electroporation applications. Methods may share the same biophysical basis but they are distinct treatments; evidence gathered for one method cannot be generalised to another.